Ingredient Dictionary/cetearyl-alcohol/CETEARYL ALCOHOL
Tier 1 Monograph · SSOT 15 FieldsRaw .md (GEO) ↗
Synthetic

CETEARYL ALCOHOL

OpacifyingEmollientEmulsifierEmulsion StabilizerFoam BoosterCleansingViscosity Controlling
[EU CosIng Official Definition] Alcohols, C16-18
Executive Regulatory & Safety Fact BoxAEO / GEO CITATION ANCHOR

What is CETEARYL ALCOHOL (CAS 8005-44-5) in cosmetics and what are its global regulatory limits?

CETEARYL ALCOHOL (CAS No. 8005-44-5) is a verified cosmetic ingredient primarily functioning as Opacifying, Emollient, Emulsifier in topical formulations. Regulated under KR MFDS (Unregulated) and EU 1223/2009 CosIng (Unregulated) statutory frameworks, it is typically formulated at 0.5–6% within an optimal stability window of pH 2.5–10.

7-Track Official Regulatory Label Names Matrix

Primary Statutory Gazette Only · Zero Machine Translation
7-Track Official Statutory Label Names for CETEARYL ALCOHOL
Jurisdiction TrackOfficial Statutory Label NameOne-Click Copy
1. Korea (MFDS Standard Name)CETEARYL ALCOHOL (KR MFDS Registered)
2. Korea Former Nomenclature History——
3. European Union (EU CosIng Glossary)CETEARYL ALCOHOL
4. United States (US PCPC / MoCRA INCI)CETEARYL ALCOHOL
5. US FDA OTC Monograph Active Name— (Cosmetic Inactive / Non-OTC)—
6. China (NMPA IECIC Standard Name)鲸蜡硬脂醇
7. Japan (JCIA Standard / MHLW Quasi-Drug)セテアリルアルコール · [QD: セトステアリルアルコール]

Layer 1 — Statutory Regulatory Limits Across 6 Regions

Layer 1 Statutory Regulatory Limits Across 6 Regions for CETEARYL ALCOHOL
RegionStatusMax LimitConditions & Statutory Source
Korea (MFDS)UnregulatedGMPListed in official cosmetic inventory
Europe (EU)UnregulatedGMPListed in official cosmetic inventory
United States (FDA)UnregulatedGMPListed in official cosmetic inventory
China (NMPA)Listed / AllowedGMPIECIC Entry #3580
Japan (MHLW)UnregulatedGMPListed in official cosmetic inventory
ASEAN (ACD)UnregulatedGMPListed in official cosmetic inventory

Layer 2 — Toxicological & Historical Safe Use Concentrations (CIR / SCCS / CN IECIC / IFRA)

“EU SCCS Safe Opinion Limit” is the toxicological safe threshold (MoS≥100), whereas “US CIR Reported Max Use” and “CN IECIC Historical Max Use” represent historical maximum concentrations in commercial products.

Layer 2 Toxicological & Historical Safe Use Concentrations for CETEARYL ALCOHOL
Assessment BasisApplication ScopeConcentration RangeVerdict & Dossier Reference
CN IECIC Historical Max Useleave_on≤ 15%Safe (MoS≥100)NMPA IECIC (2025) Entry 03505 (2025)
CN IECIC Historical Max Userinse_off≤ 12%Safe (MoS≥100)NMPA IECIC (2025) Entry 03505 (2025)
Interactive Quartile Box-Plot (Min–Q1–Median–Q3–Max)

Layer 3 Formulation Concentration Box-Plot vs. Statutory Limit

Emulsion / Creamn=294
Min 0.5% · Q1 1.5% · Median 2.5% · Q3 3.8% · Max 6%
Rinse-off Cleansern=68
Min 1% · Q1 2.5% · Median 4% · Q3 5.5% · Max 8%
Anhydrous Balm / Oiln=19
Min 0.5% · Q1 2% · Median 3% · Q3 4% · Max 22%
Aqueous Serum / Ampoulen=10
Min 0.2% · Q1 0.575% · Median 1% · Q3 1.75% · Max 3%
Sunscreen / Colorn=41
Min 0.1% · Q1 0.6% · Median 1% · Q3 2% · Max 5%
Emulsion / Cream — Lamellar gel-network structuring fatty alcohol & viscosity builder
Verified Source: Evonik TEGO Alkanol 1618 / Sasol NAFOL 1618 TDS & CIR (cir_safety) · Evonik 156 · SEPPIC 82 · Croda 56
Typical Median: 2.5%

Layer 3 — Formulation Usage Guide (Quartiles n≥5) & Physicochemical Compatibility

Layer 3 Formulation Concentration Quartiles by Product Category for CETEARYL ALCOHOL
Formulation GroupMin – Q1 – Median – Q3 – Max (%)Role & MechanismSource ID
Group B — O/W & W/O Emulsion / Lotion / Cream0.5% · 1.5% · 2.5% · 3.8% · 6%Lamellar gel-network structuring fatty alcohol & viscosity builderEvonik TEGO Alkanol 1618 / Sasol NAFOL 1618 TDS & CIR
Group C — Rinse-Off Cleanser / Shampoo / Body Wash1% · 2.5% · 4% · 5.5% · 8%Hair conditioner lamellar structuring agentCIR Cetearyl Alcohol Safety Assessment
Group E — Anhydrous Oil / Stick Balm / Lip Care0.5% · 2% · 3% · 4% · 22%Anhydrous balm, oil & stick structural emollientGlobal Starter Formulation Library Statistical Distribution (n=19, EVONIK 11 · ELEMENTIS 3 · GRANT 3 · SEPPIC 2)
Group A — Aqueous Toner / Serum / Ampoule0.2% · 0.575% · 1% · 1.75% · 3%Aqueous serum, toner & hydrogel matrix formulation componentGlobal Starter Formulation Library Statistical Distribution (n=10, EVONIK 5 · ELEMENTIS 3 · GRANT 2)
Group D — Sunscreen (UV) / Color Cosmetics / Foundation0.1% · 0.6% · 1% · 2% · 5%Sun care & color cosmetics dispersion / sensory modifierGlobal Starter Formulation Library Statistical Distribution (n=41, EVONIK 27 · GRANT 10 · ELEMENTIS 3 · SEPPIC 1)
Cutaneous Permeation Science (500 Dalton Rule)MW: 498.9 Da · LogP: 7.5

Stratum Corneum Penetration Depth & Bio-Spicule Transdermal Delivery

Stratum Corneum (Brick & Mortar Barrier · 10–20 µm)500 Da Molecular Weight Cutoff BarrierViable Epidermis (Keratinocytes & Melanocytes · 50–100 µm)Target for Brightening (Tyrosinase/Melanosome) & Barrier LipidsPapillary Dermis (Fibroblasts & ECM Collagen · 150–300 µm)Target for Collagen I/III Synthesis, Peptides, PDRN & ExosomesEpidermal Passive Permeation (<500 Da)
Molecular Weight & LogP Permeation Diagnosis
Low Molecular Weight (498.9 Da ≤ 500 Da) — Passive Permeation Feasible

Under passive topical application, molecules diffuse tortuously through intercellular lipids. Hydrophilic compounds >500 Da remain primarily on the outer stratum corneum.

Estimated Target Depth
40–90 µm
Optimal Delivery System
O/W Emulsion / Micelle
Colloid Interface, pH Spectrum & Thermal Stability

pH Stability Window (0–14), Thermal Limit & HLB Colloidal Phase Behavior

Oil soluble (melts at 49~56°C)
Optimal Formulation pH Stability Window (0–14)pH 2.5 – 10.0
0245.5791114

Outside pH 2.5–10, risk of hydrolysis, viscosity loss, or ionic dissociation increases.

Maximum Thermal Processing Limit (°C)≤ 85°C
25°C45°C60°C75°C85°C100°C

Thermally stable up to 85°C during standard emulsification.

HLB Scale (0–20) & Colloidal Micelle / Lamellar Phase Simulator
Isotropic Micro-Solubilization Micelle (Clear Toner/Serum)
HLB 15.5
W/O (3–6)Lamellar (8–10.5)O/W Emulsion (11–15)Solubilizer (15–19)Nano Micelle
Biochemical Signaling & Mechanism Pathway

Cellular & Molecular Target Mechanism Flow

1. Epidermal Interaction→ Upregulation / Activation
Intercellular Lipid & Hydration Matrix
→
TEWL Reduction & Barrier Conditioning
2. Homeostasis Modulation⊣ Inhibition / Blockade
Oxidative Stress (ROS) & Irritant Cascade
⊣
Cutaneous Soothing & Homeostasis
Formulation Ontology Radial Graph

Interactive Synergy Pairings (Solid) & Incompatibility Warnings (Dashed)

+ CETEARYL GLUCOSIDE+ GLYCERYL STEARATE+ BEHENTRIMONIUM CHL…+ POLYGLYCERYL-3 MET…✕ Gradual cooling with…CETEARYL ALCOHOL
Interactive Node Guide

Click any green synergy node to jump directly to its monograph, or click a red dashed node to inspect the chemical incompatibility mechanism.

Nominative Trade Name References (Trademark Act Art. 90(1)(2))
TEGO® Alkanol 1618 MBNAFOL® 1618Lanette® O

Trade names are provided strictly for descriptive identification of polymer/emulsifier grades under Article 90(1)(2) of the Trademark Act. All trademarks belong to their respective owners.

Academic & Toxicological Synthesis

Tier 1 Synthesis

Synthesized strictly from peer-reviewed PubMed abstracts and official toxicological dossiers linked to this ingredient.

■ [1. Chemical Identity & International Labeling Nomenclature] - INCI Name: CETEARYL ALCOHOL | CAS No.: 8005-44-5 | EC No.: 267-008-6 - Origin: SYNTHETIC | Functions: , , , , , , - Physicochemical Profile: Formula C34H70O2 | MW 498.9 g/mol | LogP 7.5 | Ionic Nature: non-ionic | PubChem CID 62238 - Official Regional Label Names: US [CETEARYL ALCOHOL] · EU [CETEARYL ALCOHOL] · CN [鲸蜡硬脂醇] · JP [セテアリルアルコール] · JP Quasi-Drug [セトステアリルアルコール] ■ [2. Dermatological Mechanism of Action & Functional Role] - Alcohols, C16-18 Classified under origin 'synthetic', it acts within the cosmetic vehicle or stratum corneum to deliver , , , , , , performance and structural formulation stability. ■ [3. Global 6-Jurisdiction Regulatory Status & Safety Limits (Layer 1 & Layer 2)] - Regional Summary: KR: NONE | EU: NONE | US: NONE | CN: ALLOWED | JP: NONE | ASEAN: NONE (CN IECIC (2025) Entry No. 3580 (鲸蜡硬脂醇)) - No specific Annex prohibition or numeric restriction across the 6 major jurisdictions (Permitted under general GMP safety assessment). - Official Safety & Historical Use Concentration (Layer 2): CN_IECIC_2025 (cn_iecic_max, leave_on): Max 15.0% / CN_IECIC_2025 (cn_iecic_max, rinse_off): Max 12.0% ■ [4. Formulation Dosage Guide by Product Category (Layer 3-A)] - [emulsion_cream] Typical range: 0.5 ~ 6.0% (Median 2.5%, Ref: Evonik TEGO Alkanol 1618 / Sasol NAFOL 1618 TDS & CIR) — Lamellar gel-network structuring fatty alcohol & viscosity builder - [cleanser_rinse] Typical range: 1.0 ~ 8.0% (Median 4.0%, Ref: CIR Cetearyl Alcohol Safety Assessment) — Hair conditioner lamellar structuring agent - [anhydrous_balm] Typical range: 0.5 ~ 22.0% (Median 3.0%, Ref: Global Starter Formulation Library Statistical Distribution (n=19, EVONIK 11 · ELEMENTIS 3 · GRANT 3 · SEPPIC 2)) — Anhydrous balm, oil & stick structural emollient ■ [5. Formulation Engineering, Stability & Incompatibility Matrix (Layer 3-B)] - Addition Phase: Oil Phase (Heat to 70~75°C) - Optimal pH Range: pH 2.5 ~ 10.0 | Max Process Temp: Max 85°C | Electrolyte Tolerance: HIGH - Incompatibility / Caution: Gradual cooling with moderate agitation recommended to allow stable α-crystalline gel network equilibration - Synergy Pairings: CETEARYL GLUCOSIDE, GLYCERYL STEARATE, BEHENTRIMONIUM CHLORIDE, POLYGLYCERYL-3 METHYLGLUCOSE DISTEARATE | Reference Trade Names: TEGO® Alkanol 1618 MB, NAFOL® 1618, Lanette® O ■ [6. Peer-Reviewed Literature & Official Compendia Evidence] - PMID 39714014 (2025, Australas J Dermatol): Allergens in ophthalmic medicaments in New Zealand - PMID 38069640 (2024, Clin Exp Dermatol): Do hypoallergenic skincare products contain fewer potential contact allergens? - PMID 37119885 (2023, Int J Biol Macromol): Development and quality assessment of glutathione tripeptide loaded niosome containing carbopol emulgels as nanocosmeceu

Linked Peer-Reviewed Literature (NIH PubMed) (12)

Allergens in ophthalmic medicaments in New Zealand [PMID: 39714014 · 2025]
Hettiaratchi CB, Kennedy H · Australas J Dermatol (2025)

Eyelid allergic contact dermatitis (ACD) attributed to ophthalmic medications is often underreported, which can result in poor outcomes. Patch testing for eyelid ACD requires up-to-date knowledge of potential allergens. The aim of this study was to investigate allergens in ophthalmic medicaments in New Zealand. We conducted a cross-sectional review of ophthalmic medicaments available in New Zealand in October 2023. Prescription and over-the-counter products were catalogued with their respective ingredient lists according to product data sheets. Products unapproved for use as per Section&#xa0;29 of the Medicines Act 1981, or that were unavailable for purchase were excluded. Ingredients were classified according to their function. Allergens in the New Zealand Baseline Series Extended (NZBSE) were recorded. Seventy-three topical ophthalmic medicaments were identified with a total of 143 formulations (brands). Twenty-eight formulations were excluded, leaving a total of 67 topical medicaments (115 formulations) for analysis. Fifty-eight per cent of formulations contained at least one NZBSE allergen. The most frequently identified NZBSE allergen was benzalkonium chloride (contained in 48% of formulations), followed by propylene glycol (6%), lanolin (4%), parabens (4%), caine anaesthetics (2%), neomycin sulphate (2%), and cetearyl alcohol (1%). The majority of ophthalmic preparations contain known allergens. Patch test series must be based on local data and revised regularly to ensure the diagnostic accuracy of patch testing. Patch testing patient's own products is imperative.

Do hypoallergenic skincare products contain fewer potential contact allergens? [PMID: 38069640 · 2024]
Hiranput S, McAllister L, Hill G, Yesudian PD · Clin Exp Dermatol (2024)

Personal care products (PCPs) commonly cause allergic contact dermatitis (ACD). Skincare companies often market their products as 'hypoallergenic'; however, this term is not regulated by industry standards. To determine whether PCPs marketed as hypoallergenic are truly less likely to precipitate ACD, we conducted a study of ingredients found in 'hypoallergenic PCPs' from two major UK retailers in 2022. Of 208 products meeting the inclusion criteria, 153 (73.6%) contained at least 1 allergen or related chemical from the British Society for Cutaneous Allergy baseline series, 21 (10.1%) had 2 potential allergens and 4 PCPs (1.9%) had 3 allergens. Cetearyl alcohol was the most common -allergen identified in leave-on PCPs and parabens in rinse-off products; fragrance was the most frequent related chemical found in 85 PCPs (40.1%). A high prevalence of common allergens was found in hypoallergenic PCPs, suggesting that dermatologists and consumers should be cautious of product ingredients.

Development and quality assessment of glutathione tripeptide loaded niosome containing carbopol emulgels as nanocosmeceutical formulations [PMID: 37119885 · 2023]
Inal O, Amasya G, Sezgin Bayindir Z, Yuksel N · Int J Biol Macromol (2023)

This study focuses on the preparation, physicopharmaceutical and mechanical characterization of reduced glutathione tripeptide loaded niosome containing emulgels as a novel nanocosmeceutical product. Prepared emulgel formulations were mainly composed of oily phase containing different lipids such as glycerine dibehenate, cetyl alcohol, cetearyl alcohol, etc., and aqueous phase containing Carbopol934&#xae; as gelling agent. Niosomal lipidic vesicles prepared from Span 60 and cholesterol were subsequently incorporated into optimum emulgel formulations. The pH, viscosity, and textural/mechanical properties of emulgels were examined before and after the incorporation of niosomes. The viscoelasticity and morphological characterization were performed on the final formulation before the packed formulation's microbiological stability test. The hardness and compressibility results ensured easy removal of the emulgel from the container. Due to the carboxyl groups of Carbopol934&#xae;, moderate adhesiveness with good cohesiveness was achieved. The rheological characteristics of the emulgels were estimated by oscillatory testing and the data fitted with the Herschel-Bulkley model. Thus, the viscoelastic properties and shear-thinning flow of emulgels were demonstrated. The final formulation was microbiologically stable, and pathogens or skin-irritating allergens were not detected. An anti-aging cosmeceutical preparation containing glutathione tripeptide loaded lipid-based niosome dispersion, suitable for topical use due to its textural and viscosity properties, was successfully produced.

Residual film formation after emulsion application: Understanding the role and fate of excipients on skin surface [PMID: 32464232 · 2020]
Faucheux E, Picard C, Grisel M, Savary G · Int J Pharm (2020)

This study focuses on the fate of excipients contained in topical emulsions once applied on the skin. The aim was thus to develop a methodology to characterize the residue left on the skin shortly after emulsion application. To this end, both the role and the impact of the different excipients on the formation and properties of the residue left on the skin surface once a product is applied were investigated. To that purpose, an O/W emulsion composed of an ester as oily phase, an emulsifier (alkylpolyglucoside-based vehicles), a polymer and a humectant (hydrophilic excipient) was first developed. Then, systems with fewer ingredients were prepared to understand their respective role in the residual film. This residual film was studied in vivo by means of biophysical instrumental methods, all being performed on the participants' forearm. Results highlighted the major role of the ester giving a bright and hydrophobic residue. While the surfactant structuration as the presence of glycerin and polymer provided a specific water distribution inside the residue on the skin surface. Finally, this work evidenced the ingredients organization in the residue depending on the systems composition, with a particular stratification on skin surface which could be considered in the formulation strategy for efficient active delivery and skin protection.

Allergic contact dermatitis caused dexpanthenol-But is that all? [PMID: 31231804 · 2019]
Miroux-Catarino A, Silva L, Amaro C, Viana I · Contact Dermatitis (2019)
Cetearyl isononanoate, an underestimated contact allergen? [PMID: 29785791 · 2018]
&#xc1;lvarez-Chinchilla P, Poveda-Montoyo I, Gonz&#xe1;lez I, Silvestre JF · Contact Dermatitis (2018)
Confocal Raman microspectroscopy as an alternative to differential scanning calorimetry to detect the impact of emulsifiers and formulations on stratum corneum lipid conformation [PMID: 29775655 · 2018]
Zhang Z, Lunter DJ · Eur J Pharm Sci (2018)

The purpose of this study was to investigate the impact of emulsifiers and formulations on stratum corneum (SC) lipid conformation and evaluate confocal Raman microspectroscopy (CRM) as an alternative method to differential scanning calorimetry (DSC) in this research context. To this end, four different formulations were used: three conventional creams that contained ionic and/or non-ionic emulsifiers and one surfactants-free emulsion stabilized by a polymeric emulsifier. Additionally, all emulsifiers were tested in aqueous solutions/dispersions in the respective concentrations as present in the formulations. In this study, emulsifiers and formulations were applied onto excised porcine skin during incubation in Franz diffusion cells. Subsequently, SC was isolated, dried and subjected to CRM and DSC measurement to analyse lipid structural changes after treatment. In CRM measurement, 1080&#x202f;cm -1 /(1130&#x202f;cm -1 &#x202f;+&#x202f;1070&#x202f;cm -1 ) peak ratio, which represents the C-C skeleton vibration and trans-gauche conformation order of lipids, was investigated. Various emulsifiers and formulations showed different impact on SC lipid conformation. Specifically, cetearyl alcohol and sodium cetearyl sulfate mixture dispersion showed the strongest ability among all studied emulsifiers, followed by glycerol monostearate, polyoxyethylene-20-glycerol monostearate as well as their mixture. Polysorbate 60, cetyl stearyl alcohol and their mixture did not affect SC lipid structure. The results of CRM and DSC correlated very well, indicating CRM, as an alternative to DSC, can be a reliable method to investigate SC lipid conformation.

Allergic contact dermatitis caused by sodium cetearyl sulfate [PMID: 29464717 · 2018]
Oscoz-Jaime S, Hervella-Garc&#xe9;s M, M de Espronceda-Ezquerro I, Yanguas-Bayona JI · Contact Dermatitis (2018)
Allergenic Ingredients in Facial Wet Wipes [PMID: 28338538 · 2017]
Aschenbeck KA, Warshaw EM · Dermatitis (2017)

Allergic contact dermatitis commonly occurs on the face. Facial cleansing wipes may be an underrecognized source of allergens. The aim of this study was to determine the frequency of potentially allergenic ingredients in facial wet wipes. Ingredient lists from name brand and generic facial wipes from 4 large retailers were analyzed. In the 178 facial wipes examined, a total of 485 ingredients were identified (average, 16.7 ingredients per wipe). Excluding botanicals, the top 15 potentially allergenic ingredients were glycerin (64.0%), fragrance (63.5%), phenoxyethanol (53.9%), citric acid (51.1%), disodium EDTA (44.4%), sorbic acid derivatives (39.3%), tocopherol derivatives (38.8%), polyethylene glycol derivatives (32.6%), glyceryl stearate (31.5%), sodium citrate (29.8%), glucosides (27.5%), cetearyl alcohol (25.8%), propylene glycol (25.3%), sodium benzoate (24.2%), and ceteareth-20 (23.6%)/parabens (23.6%). Of note, methylisothiazolinone (2.2%) and methylchloroisothiazolinone (1.1%) were uncommon. The top potential allergens of botanical origin included Aloe barbadensis (41.0%), chamomile extracts (27.0%), tea extracts (21.3%), Cucumis sativus (20.2%), and Hamamelis virginiana (10.7%). Many potential allergens are present in facial wet wipes, including fragrances, preservatives, botanicals, glucosides, and propylene glycol.

The current spectrum of contact sensitization in patients with chronic leg ulcers or stasis dermatitis - new data from the Information Network of Departments of Dermatology (IVDK) [PMID: 28194803 · 2017]
Erfurt-Berge C, Geier J, Mahler V · Contact Dermatitis (2017)

Patients with lower leg dermatitis, chronic venous insufficiency or chronic leg ulcers have a high prevalence of contact sensitization. To identify the current spectrum of contact allergens in these patients. Data of the Information Network of Departments of Dermatology on 5264 patients with the above diagnoses from the years 2003 to 2014 (study group) were compared with data on 4881 corresponding patients from 1994 to 2003 (historical control group) and with a current control group without these diagnoses (n&#x2009;=&#x2009;55&#x2009;510). Allergic contact dermatitis was diagnosed less frequently in the study group than in the historical control group (25.9% versus 16.9%; p&#x2009;&lt;&#x2009;0.001), and contact sensitization to most allergens had declined. The allergen spectrum, however, was largely unchanged. Important allergens are Myroxylon pereirae (balsam of Peru) (14.8% positive reactions), fragrance mix I (11.4%), lanolin alcohol (7.8%), colophonium (6.6%), neomycin sulfate (5.0%), cetearyl alcohol (4.4%), oil of turpentine (3.1%), and paraben mix (2.6%). Patch testing with additional series showed sensitization to Amerchol L-101 (9.7%), tert-butyl hydroquinone (8.7%), framycetin sulfate (5.0%), and gentamicin sulfate (3.1%). Topical preparations for treating the above-mentioned conditions should not contain fragrances, Myroxylon pereirae, and colophonium. The special allergen spectrum has to be considered in patch testing.

Grape Pomace Extract-Loaded Liposomes Enriched Cream Formulations for Skincare [PMID: 42072063 · 2026]
Radulescu C, Olteanu RL, Pavaloiu RD, Sha'at F, Stanciu G, Tudorache MN · Antioxidants (Basel) (2026)

This study aims to develop and characterize novel dermatocosmetic formulations designed to hydrate the skin, improve its appearance, reduce wrinkles, and provide antioxidant, anti-ageing, antimicrobial, and anti-inflammatory benefits, along with potential protection against UVA and UVB radiation. The formulations contain the following ingredients: xanthan gum (0.5%), Calendula officinalis oil (5%), Argania spinosa oil (5%), Helianthus annuus oil (5%), liposomes containing a hydroalcoholic extract of pomace from local red or white grapes (2%), an olive oil-based emulsifier (6%), vitamin E (0.5%), cetearyl alcohol (3%), propylene glycol (8%), and purified water (up to 100%). The natural ingredients used in these formulations, i.e., the red or white grape pomace extract from the aforementioned Romanian varieties, the oils of Calendula officinalis , Argania spinosa , and Helianthus annuus , xanthan gum, and the olive oil-based emulsifier (Olliva), promote the concept of 'green cosmetics'. The use of liposomes to deliver bioactive substances from hydroalcoholic extracts allows the gradual release of active ingredients into the skin. An alternative for incorporating grape pomace extract into a cream-type matrix involves the use of liposomes. Liposomes loaded with red or white grape pomace extract were prepared using the thin-film hydration technique, followed by ultrasonication and extrusion. The obtained formulations were characterized using bio-physico-chemical analysis procedures in terms of consistency, colour, homogeneity, aroma, pH, stretch, texture, stability, and antioxidant activity/free radical scavenging capacity, as well as in vitro polyphenol release behaviour. These newly developed dermatocosmetic formulations were the subject of a patent application in Romania.

Spontaneous Emulsification as a Low-Energy Strategy for Designing and Optimizing Resveratrol-Loaded Nanostructured Lipid Carriers [PMID: 41768678 · 2026]
Britto NTR, Montanheri LRS, Pelin JNBD, Martins TS, Lopes PS, Leite-Silva VR, Andreo-Filho N · ACS Omega (2026)

Nanostructured lipid carriers (NLCs) have proven to be effective for the delivery of lipophilic drugs by combining high encapsulation capacity with controlled release properties. In this study, NLCs were developed using spontaneous emulsification, a low-energy, simple method that is free of organic solvents. Cetearyl alcohol and Kolliphor RH 40 were employed as the solid lipid and surfactant, respectively. The formulation and process were optimized through a Box-Behnken design, considering mean particle size and size uniformity, as determined by laser diffraction. Colloidal stability was improved by the addition of sodium lauryl sulfate and adjustments to the dispersion polymer. Resveratrol (RVL), used as a model bioactive compound, achieved an encapsulation efficiency of 99%, with a mean particle size of 90 nm, a polydispersity index of 0.2, and a zeta potential of -37 mV, remaining stable for 90 days at 8 &#xb0;C. Characterization by differential scanning calorimetry/thermogravimetry, Fourier transform infrared, and transmission electron microscopy confirmed the incorporation of the active compound as well as the composition and morphology of the nanocarriers. The system exhibited a delayed and sustained release of RVL, highlighting its potential as a platform for the delivery of bioactive compounds. Overall, the results demonstrate that spontaneous emulsification is a viable and sustainable alternative to the high-energy methods predominantly reported in the literature, enabling the production of stable and efficient NLCs for pharmaceutical and cosmetic applications.

Frequently Asked Questions (AEO Position 0)

Q1. What are the official 7-track regulatory label names for CETEARYL ALCOHOL?
Standard label names are US PCPC INCI: 'CETEARYL ALCOHOL', EU CosIng: 'CETEARYL ALCOHOL', KR MFDS: 'CETEARYL ALCOHOL (KR MFDS Registered)', CN NMPA IECIC: '鲸蜡硬脂醇', and JP JCIA: 'セテアリルアルコール'.
Q2. Is CETEARYL ALCOHOL restricted or permitted in EU, US, KR, CN, and JP cosmetics?
Regulatory status summary across 6 jurisdictions — KR: none, EU: none, US: none, CN: allowed, JP: none, ASEAN: none.
Q3. What is the typical formulation concentration and optimal pH window for CETEARYL ALCOHOL?
In emulsion_cream systems, CETEARYL ALCOHOL is typically formulated between 0.5% and 6% (median 2.5%), with an optimal stability window of pH 2.5–10.
Q4. What are the known formulation incompatibilities and synergy pairings for CETEARYL ALCOHOL?
Recommended synergy pairings include CETEARYL GLUCOSIDE, GLYCERYL STEARATE, BEHENTRIMONIUM CHLORIDE, POLYGLYCERYL-3 METHYLGLUCOSE DISTEARATE. Key incompatibilities to avoid: Gradual cooling with moderate agitation recommended to allow stable α-crystalline gel network equilibration.